PDEX
Pro-Dex, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Neutral
+13/100
Last price
64.92
▼ 0.48 (0.74%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
65.41
Day high
66.68
Day low
64.03
Volume
71.54K
Market cap
$207.96M
P/E (TTM)
15.76
52W range
23.47 – 77.00
Trailing performance
Returnvs SPY
1W
-7.28%
-9.2%
1M
-11.57%
-12.7%
3M
+8.62%
+4.1%
6M
+30.41%
+12.2%
YTD
+68.71%
+54.5%
1Y
+90.77%
+74.4%
3Y
+313.50%
+231.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PDEX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-879
Net selling
Buy transactions
4
32.42K shares
Sell transactions
5
33.30K shares
Net transactions
+9
Buys less sells
Sell : buy shares
1.0 : 1
Mixed
Insider-held shares
1.16M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 11, 26 | VAN KIRK RICHARD LEE JR Chief Executive Officer |
SELL | 765 | $45.41K | Direct |
| Sep 9, 26 | CHARLTON ALISHA K Chief Financial Officer |
SELL | 2.30K | $140.98K | Direct |
| Sep 9, 26 | VAN KIRK RICHARD LEE JR Chief Executive Officer |
SELL | 19.23K | $1.17M | Direct |
| Jul 23, 26 | DOMINGO ANGELITA REBAMONTAN Director |
STOCK | 19 | $1.04K | Direct |
| Jul 1, 26 | CHARLTON ALISHA K Chief Financial Officer |
STOCK | 10.80K | $0 | Direct |
| Jul 1, 26 | VAN KIRK RICHARD LEE JR Chief Executive Officer |
STOCK | 14.80K | $0 | Direct |
| Jul 1, 26 | DOMINGO ANGELITA REBAMONTAN Director |
STOCK | 6.80K | $0 | Direct |
| May 22, 26 | VAN KIRK RICHARD LEE JR Chief Executive Officer |
SELL | 10.00K | $626.25K | Direct |
| Mar 16, 26 | DOMINGO ANGELITA REBAMONTAN Director |
SELL | 998 | $47.15K | Direct |
| Jan 22, 26 | DOMINGO ANGELITA REBAMONTAN Director |
STOCK | 18 | $618 | Direct |
| Nov 21, 25 | PHILP KATRINA MARIE KRAMER Director |
STOCK | 3.10K | $101.40K | |
| Nov 20, 25 | CABILLOT RAYMOND E Director and Beneficial Owner of more than 10% of a Class of Security |
STOCK | 1.00K | $0 | Direct |
| Nov 20, 25 | HOVDA DAVID C Director |
STOCK | 1.00K | $0 | Direct |
| Nov 20, 25 | CHARLTON ALISHA K Chief Financial Officer |
STOCK | 1.00K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CABILLOT RAYMOND E |
Director and Beneficial Owner of more than 10% of a Class of Security | 272.85K | Stock Award(Grant) |
CHARLTON ALISHA K |
Chief Financial Officer | 21.87K | Sale |
DOMINGO ANGELITA REBAMONTAN |
Director | 18.80K | Stock Award(Grant) |
FARRELL WILLIAM JAMES III |
Director | 7.10K | Stock Award(Grant) |
HOVDA DAVID C |
Director | 4.30K | Stock Award(Grant) |
PHILP KATRINA MARIE KRAMER |
Director | — | Stock Award(Grant) |
SWENSON NICHOLAS JOHN |
Director and Beneficial Owner of more than 10% of a Class of Security | 1.02M | Stock Award(Grant) |
VAN KIRK RICHARD LEE JR |
Chief Executive Officer | 79.23K | Sale |
Fundamentals
Market cap$207.96M
Enterprise value$217.56M
Revenue (TTM)$77.55M
Gross profit$24.34M
EBITDA$14.38M
Net income$13.66M
EPS (TTM)$4.12
Free cash flow$5.40M
Total cash$9.34M
Total debt$18.94M
Book value / share$14.95
Shares outstanding3.20M
Float1.76M
Short % of float28.81%
Dividend yield0.00%
Beta (5Y)0.04
Valuation & profitability ratios
Trailing P/E15.76
Forward P/E19.32
PEG ratio—
Price / sales—
Price / book4.34
EV / revenue2.81
EV / EBITDA15.12
Gross margin31.38%
Operating margin17.29%
Profit margin17.62%
Return on equity32.43%
Return on assets11.97%
Debt / equity39.77
Current ratio4.10
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $77.55M | $66.59M | $53.84M | $46.09M | +16.5% |
| Operating revenue | $77.80M | $67.89M | $55.24M | $47.17M | +14.6% |
| Cost of revenue | $53.21M | $47.08M | $39.29M | $33.34M | +13.0% |
| Gross profit | $24.34M | $19.51M | $14.55M | $12.75M | +24.7% |
| Research & development | $3.35M | $3.64M | $3.19M | $2.80M | -8.0% |
| Selling, general & admin | $8.00M | $5.18M | $4.19M | $4.18M | +54.3% |
| Total operating expense | $11.34M | $8.82M | $7.38M | $6.99M | +28.6% |
| Operating income | $12.99M | $10.69M | $7.17M | $5.76M | +21.5% |
| Net interest income | -$631.00K | -$747.00K | -$414.00K | -$239.00K | +15.5% |
| Pre-tax income | $18.02M | $12.06M | $2.63M | $9.43M | +49.4% |
| Tax provision | $4.35M | $3.08M | $507.00K | $2.35M | +41.3% |
| Net income | $13.66M | $8.98M | $2.13M | $7.07M | +52.2% |
| Net income to common | $13.66M | $8.98M | $2.13M | $7.07M | +52.2% |
| Basic EPS | 4.24 | 2.73 | 0.61 | 1.98 | +55.3% |
| Diluted EPS | 4.12 | 2.67 | 0.60 | 1.95 | +54.3% |
| EBIT | $18.83M | $12.89M | $3.19M | $9.96M | +46.1% |
| EBITDA | $20.22M | $14.13M | $4.35M | $10.82M | +43.1% |
| Basic shares | 3.23M | 3.29M | 3.50M | 3.57M | -1.9% |
| Diluted shares | 3.32M | 3.36M | 3.57M | 3.64M | -1.3% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $8.19M | $419.00K | $2.63M | $2.94M | +1,855.1% |
| Cash & short-term investments | $9.34M | $7.16M | $6.85M | $4.07M | +30.5% |
| Accounts receivable | $21.20M | $16.43M | $13.89M | $9.95M | +29.0% |
| Inventory | $21.46M | $22.21M | $15.27M | $16.17M | -3.4% |
| Total current assets | $53.25M | $47.30M | $36.61M | $30.98M | +12.6% |
| Property, plant & equipment | $11.94M | $12.26M | $12.65M | $13.20M | -2.6% |
| Goodwill & intangibles | $7.21M | $26.00K | $54.00K | $81.00K | +27,634.6% |
| Total assets | $74.51M | $61.19M | $52.48M | $51.82M | +21.8% |
| Total current liabilities | $12.98M | $14.63M | $12.89M | $9.68M | -11.3% |
| Current debt | $4.21M | $6.15M | $4.37M | $3.83M | -31.6% |
| Long-term debt | $13.27M | $9.25M | $7.54M | $8.91M | +43.5% |
| Total debt | $18.94M | $16.58M | $13.55M | $14.79M | +14.3% |
| Total liabilities | $26.88M | $24.56M | $21.61M | $20.23M | +9.4% |
| Retained earnings | $47.63M | $35.93M | $26.95M | $24.82M | +32.6% |
| Shareholder equity | $47.63M | $36.63M | $30.87M | $31.59M | +30.0% |
| Working capital | $40.27M | $32.67M | $23.72M | $21.30M | +23.3% |
| Net tangible assets | $40.42M | $36.61M | $30.81M | $31.51M | +10.4% |
| Shares issued | 3.19M | 3.26M | 3.36M | 3.55M | -2.3% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $13.66M | $8.98M | $2.13M | $7.07M | +52.2% |
| Depreciation & amortisation | $1.39M | $1.24M | $1.16M | $857.00K | +12.5% |
| Stock-based compensation | $688.00K | $555.00K | $605.00K | $766.00K | +24.0% |
| Change in working capital | -$3.05M | -$10.45M | -$225.00K | $396.00K | +70.8% |
| Operating cash flow | $7.24M | -$1.68M | $6.22M | $5.46M | +530.6% |
| Capital expenditure | -$483.00K | -$1.25M | -$983.00K | -$974.00K | +61.2% |
| Investing cash flow | $3.91M | -$238.00K | -$2.23M | -$885.00K | +1,744.1% |
| Share buybacks | -$3.41M | -$3.50M | -$3.50M | -$1.55M | +2.7% |
| Financing cash flow | -$3.38M | -$292.00K | -$4.30M | -$2.49M | -1,058.2% |
| Free cash flow | $6.76M | -$2.93M | $5.24M | $4.49M | +330.8% |
| End cash position | $8.19M | $419.00K | $2.63M | $2.94M | +1,855.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $20.41M | $19.95M | $18.66M | $18.53M | $17.49M | — | +2.3% |
| Operating revenue | $20.36M | $19.92M | $18.66M | $18.86M | $17.96M | — | +2.2% |
| Cost of revenue | $13.31M | $13.82M | $12.92M | $13.16M | $14.00M | — | -3.6% |
| Gross profit | $7.09M | $6.13M | $5.74M | $5.37M | $3.49M | — | +15.6% |
| Research & development | $1.02M | $827.00K | $734.00K | $768.00K | $905.00K | — | +23.0% |
| Selling, general & admin | $2.54M | $2.21M | $1.75M | $1.49M | $1.24M | — | +15.1% |
| Total operating expense | $3.56M | $3.04M | $2.48M | $2.26M | $2.15M | — | +17.2% |
| Operating income | $3.53M | $3.09M | $3.26M | $3.11M | $1.34M | — | +14.1% |
| Net interest income | -$216.00K | -$148.00K | -$81.00K | -$186.00K | -$206.00K | — | -45.9% |
| Pre-tax income | $3.52M | $5.34M | $2.93M | $6.22M | $1.60M | — | -34.0% |
| Tax provision | $668.00K | $1.40M | $741.00K | $1.54M | $402.00K | — | -52.4% |
| Net income | $2.86M | $3.94M | $2.19M | $4.68M | $1.20M | — | -27.5% |
| Net income to common | $2.86M | $3.94M | $2.19M | $4.68M | $1.20M | — | -27.5% |
| Basic EPS | — | 1.23 | 0.67 | 1.43 | 0.37 | 1.00 | — |
| Diluted EPS | — | 1.20 | 0.66 | 1.40 | 0.36 | 0.98 | — |
| EBIT | $3.79M | $5.54M | $3.07M | $6.42M | $1.83M | — | -31.5% |
| EBITDA | $4.20M | $5.90M | $3.38M | $6.73M | $2.14M | — | -28.8% |
| Basic shares | — | 3.20M | 3.25M | 3.26M | 3.26M | 3.26M | — |
| Diluted shares | — | 3.27M | 3.30M | 3.34M | 3.35M | 3.34M | — |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.19M | $9.99M | $7.95M | $514.00K | $419.00K | -18.0% |
| Cash & short-term investments | $9.34M | $10.98M | $8.82M | $10.55M | $7.16M | -14.9% |
| Accounts receivable | $21.20M | $19.47M | $17.88M | $18.23M | $16.43M | +8.9% |
| Inventory | $21.46M | $22.36M | $21.71M | $21.56M | $22.21M | -4.0% |
| Total current assets | $53.25M | $53.71M | $49.19M | $50.72M | $47.30M | -0.9% |
| Property, plant & equipment | $11.94M | $12.24M | $11.60M | $11.95M | $12.26M | -2.4% |
| Goodwill & intangibles | $7.21M | $7.24M | $12.00K | $19.00K | $26.00K | -0.4% |
| Total assets | $74.51M | $74.98M | $62.26M | $64.30M | $61.19M | -0.6% |
| Total current liabilities | $12.98M | $14.64M | $12.20M | $13.60M | $14.63M | -11.3% |
| Current debt | $4.21M | $4.19M | $2.47M | $4.61M | $6.15M | +0.3% |
| Long-term debt | $13.27M | $14.30M | $8.01M | $8.63M | $9.25M | -7.3% |
| Total debt | $18.94M | $19.33M | $10.89M | $13.79M | $16.58M | -2.0% |
| Total liabilities | $26.88M | $29.78M | $20.63M | $22.79M | $24.56M | -9.7% |
| Retained earnings | $47.63M | $45.20M | $41.63M | $40.61M | $35.93M | +5.4% |
| Shareholder equity | $47.63M | $45.20M | $41.63M | $41.51M | $36.63M | +5.4% |
| Working capital | $40.27M | $39.07M | $36.98M | $37.12M | $32.67M | +3.0% |
| Net tangible assets | $40.42M | $37.96M | $41.62M | $41.49M | $36.61M | +6.5% |
| Shares issued | 3.19M | 3.20M | 3.21M | 3.26M | 3.26M | -0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $2.86M | $3.94M | $2.19M | $4.68M | $1.20M | — | -27.5% |
| Depreciation & amortisation | $406.00K | $363.00K | $314.00K | $311.00K | $314.00K | — | +11.8% |
| Stock-based compensation | $177.00K | $186.00K | $164.00K | $161.00K | $154.00K | — | -4.8% |
| Change in working capital | -$3.60M | -$423.00K | $514.00K | $461.00K | -$1.50M | — | -751.3% |
| Operating cash flow | -$273.00K | $1.63M | $3.57M | $2.31M | -$173.00K | — | -116.7% |
| Capital expenditure | -$203.00K | -$112.00K | — | — | -$93.00K | -$180.00K | -81.3% |
| Investing cash flow | $198.00K | -$5.05M | $8.87M | -$98.00K | -$992.00K | — | +103.9% |
| Share buybacks | -$600.00K | -$601.00K | -$2.21M | $0 | $0 | — | +0.2% |
| Financing cash flow | -$1.73M | $5.46M | -$5.00M | -$2.12M | -$2.89M | — | -131.6% |
| Free cash flow | -$476.00K | $1.52M | $3.40M | $2.31M | -$266.00K | — | -131.3% |
| End cash position | $8.19M | $9.99M | $7.95M | $514.00K | $419.00K | — | -18.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | — | 0.87 | — |
| Mar 2026 | — | 1.20 | — |
| Sep 2025 | 0.50 | 1.40 | +180.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.67 | 1 | $20.40M | +10.1% |
| Next quarter | 0.72 | 1 | $20.50M | — |
| Current year | 3.09 | 1 | $82.70M | +6.6% |
| Next year | 3.36 | 1 | $86.80M | +5.0% |
Analyst targets & ownership
Mean target$74.00
High target$74.00
Low target$74.00
Implied upside13.99%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders36.26%
Held by institutions31.74%
Institutions holding104
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
68.71
-5.52% from price
SMA 20
68.14
-4.72% from price
SMA 50
65.96
-1.57% from price
SMA 100
63.76
+1.82% from price
SMA 200
54.70
+18.69% from price
EMA 12
67.58
-3.94% from price
EMA 26
67.39
-3.66% from price
EMA 50
65.91
-1.51% from price
RSI (14)
44.6
Neutral
MACD (12,26,9)
0.19
Hist -0.93
ATR (14)
3.06
4.71% of price
Realised vol 30D
76.9%
Annualised
Bollinger upper
76.37
20, 2σ
Bollinger lower
59.90
20, 2σ
50 / 200 cross
Golden
65.96 vs 54.70
Trend bias
Above 200
+18.69%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.04
More volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
76.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-31.2%
Peak to trough
Max drawdown 5Y
-65.3%
Peak to trough
ATR 14
3.06
4.71% of price
Beta (reported)
0.04
5Y monthly, from filing
Short interest
Shares short
209.91K
Prior 194.18K
Change vs prior
+8.1%
Shorts adding
% of float
28.81%
Heavily shorted
% of shares out
6.55%
Against total outstanding
Days to cover
3.0
Liquid
Float
1.76M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 11, 26 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| May 12, 26 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| May 27, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Feb 22, 25 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Nov 11, 24 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Sep 9, 24 | Ascendiant Capital | MAINTAINED | Buy | Buy |
| Jan 4, 17 | Ascendiant Capital | INITIATED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:3
Split dateJun 18, 2010
SEC filings
Proxy Statements
DEF 14A · 2026-10-06
Corporate Changes & Voting Matters
8-K · 2026-09-18
Corporate Changes & Voting Matters
8-K · 2026-09-03
Corporate Changes & Voting Matters
8-K · 2026-08-28
Corporate Changes & Voting Matters
8-K · 2026-06-17
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-01
Corporate Changes & Voting Matters
8-K · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-03-27
Headlines
Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex
Zacks · 5d ago
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Zacks · 6d ago
Best Momentum Stocks to Buy for September 18th
Zacks · 19d ago
New Strong Buy Stocks for September 18th
Zacks · 19d ago
Dell Afterglow Continues. These Other Stocks Top Buy Points.
Investor's Business Daily · 33d ago
Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results
ACCESS Newswire · 34d ago
Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates
Zacks · 55d ago
Pro-Dex Inc (PDEX) Positioned to Strengthen with Zimmer’s mBos Robot Commercialization
Insider Monkey · 58d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.